Garratty G. Predicting the clinical significance of alloantibodies and determining the in vivo survival of transfused red cells. In: Judd WJ, Barnes A, eds. Clinical and serological aspects of transfusion reactions: a technical workshop. Washington, DC: American Association of Blood Banks, 1982:91-119.Search in Google Scholar
Zupanska B. Cellular immunoassays and their use for predicting the clinical significance of antibodies.In:Garratty G,ed.Immunobiology of transfusion medicine. New York: Dekker, 1994:465-91.Search in Google Scholar
Englefriet CP, Overbeeke MAM, Dooren MC, Ouwehand WH,von dem Borne AEGKr. Bioassays to determine the clinical significance of red cell alloantibodies based on Fc receptor-induced destruction of red cells sensitized by IgG. Transfusion 1994;34:617-26.10.1046/j.1537-2995.1994.34794330018.x8053042Search in Google Scholar
Hadley AG.A comparison of in vitro tests for predicting the severity of haemolytic disease of the fetus and newborn. Vox Sang 1998;74(Suppl. 2): 375-83.10.1111/j.1423-0410.1998.tb05445.x9704470Search in Google Scholar
Mollison PL. Determination of red cell survival using 51Cr. In: Bell CA, ed. A seminar on immune-mediated cell destruction. Washington, DC: American Association of Blood Banks, 1981:45-69.Search in Google Scholar
Silvergleid AJ, Wells RF, Hafleigh EB, et al. Compatibility test using 51chromium-labeled red blood cells in crossmatch positive patients. Transfusion 1978;18:8-14.10.1046/j.1537-2995.1978.18178118571.x625785Search in Google Scholar
Garratty G. Factors affecting the pathogenicity of red cell auto- and alloantibodies. In: Nance SJ, ed. Immune destruction of red blood cells. Arlington, VA: American Association of Blood Banks, 1989: 109-69.Search in Google Scholar
Hadley AG, Kumpel BM, Merry AH. The chemiluminescent response of human monocytes to red cells sensitized with monoclonal anti-Rh(D) antibodies. Clin Lab Haematol 1988;10:377-84.10.1111/j.1365-2257.1988.tb01184.x3150696Search in Google Scholar
Garratty G,Arndt P, Nance S.IgG subclass of blood group alloantibodies to high frequency antigens (abstract).Transfusion 1996;36:50S.10.Engelfriet CP, Reesink HW. Laboratory procedures for the prediction of the severity of haemolytic disease of the newborn.Vox Sang 1995;69:61-9.10.1111/j.1423-0410.1995.tb00349.xSearch in Google Scholar
Judd WJ. Practice guidelines for prenatal and perinatal immunohematology, revisited. Transfusion 2001;41:1445-52.10.1046/j.1537-2995.2001.41111445.x11724993Search in Google Scholar
International Committee for Standardization in Haematology. Recommended method for radioisotope red-cell survival studies. Br J Haematol 1980; 45:659-66.10.1111/j.1365-2141.1980.tb07189.x7426443Search in Google Scholar
Mollison PL. Survival in vivo as a test for red cell compatibility. Haematologia 1972;6:139-45.Search in Google Scholar
Nance SJ,Arndt P,Garratty G. Predicting the clinical significance of red cell alloantibodies using a monocyte monolayer assay.Transfusion 1987;27:449-52.10.1046/j.1537-2995.1987.27688071692.x3686653Search in Google Scholar
Davey RJ, Esty SS, Chin JF,Mallory D.A comparison of the monocyte monolayer assay with 51chromium red cell recovery for determining the clinical significance of red cell alloantibodies. Immunohematology 1994;10:90-4.10.21307/immunohematology-2019-929Search in Google Scholar
Schanfield MS, Stevens JO, Bauman D.The detection of clinically significant erythrocyte alloantibodies using a human mononuclear phagocyte assay. Transfusion 1981;21:571-6.10.1046/j.1537-2995.1981.21582040822.x6794195Search in Google Scholar
Urbaniak SJ, Greiss MA, Crawford RJ, Fergusson MJC. Prediction of the outcome of Rhesus haemolytic disease of the newborn: Additional information using an ADCC assay. Vox Sang 1984; 46:323-9.10.1111/j.1423-0410.1984.tb00093.xSearch in Google Scholar
Engelfriet CP, Ouwehand WH. ADCC and other cellular bioassays for predicting the clinical significance of red cell alloantibodies. Baillieres Clin Haematol 1990;3:321-37.10.1016/S0950-3536(05)80053-8Search in Google Scholar
Nance SJ, Nelson JM, Horenstein J,et al. Monocyte monolayer assay: an efficient noninvasive technique for predicting the severity of hemolytic disease of the newborn. Am J Clin Pathol 1989;92: 89-92.10.1093/ajcp/92.1.892750714Search in Google Scholar
Larson PJ, Thorp JM, Miller RC, Hoffman M.The monocyte monolayer assay: a noninvasive technique for predicting the severity of in utero hemolysis. Am J Perinatol 1995;12:157-60.10.1055/s-2007-9944407612085Search in Google Scholar
Hadley A, Wilkes A, Poole J, Arndt P, Garratty G.A chemiluminescence test for predicting the outcome of transfusing incompatible blood. Transfus Med 1999;9:337-42.10.1046/j.1365-3148.1999.00218.x10583888Search in Google Scholar
Garratty G,Arndt P. Determining the clinical significance of blood group alloantibodies: a reevaluation of the interpretation of monocyte monolayer assay results (abstract). Blood 1998;92:563a.Search in Google Scholar
Garratty G. Evaluating the clinical significance of blood group alloantibodies that are causing problems in pretransfusion testing. Vox Sang 1998; 74(Suppl. 2):285-90.10.1111/j.1423-0410.1998.tb05433.x9704458Search in Google Scholar
Garratty G, Arndt P, Nance S.The potential clinical significance of blood group alloantibodies to high frequency antigens. Blood 1997;90(Suppl 1):473a.Search in Google Scholar
Sacks DA, Nance SJ, Garratty G,et al. Monocyte monolayer assay as a predictor of severity of hemolytic disease of the fetus and newborn.Am J Perinatol 1993;10:428-31.10.1055/s-2007-9946238267805Search in Google Scholar
Garner SF, Gorick BD, Lai WYY, et al. Prediction of the severity of haemolytic disease of the newborn. Vox Sang 1995;68:169-76.10.1159/000462922Search in Google Scholar
Lucas GF, Hadley AG, Nance SJ, Garratty G. Predicting hemolytic disease of the newborn: a comparison of the monocyte monolayer assay and the chemiluminescence test. Transfusion 1993; 33:484-7.10.1046/j.1537-2995.1993.33693296810.x8516790Search in Google Scholar
Zupanska B, Lenkiewicz B, Michalewska B, Rokicki T.The ability of cellular assays to predict the necessity for cordocenteses in pregnancies at risk of haemolytic disease of the newborn (letter). Vox Sang 2001;80:234.10.1046/j.1423-0410.2001.00033.x11438032Search in Google Scholar
Oepkes D,van Kamp IL, Simon MJG, et al. Clinical value of an antibody-dependent cell-mediated cytotoxicity assay in the management of Rh D alloimmunization. Am J Obstet Gynecol 2001;184: 1015-20.10.1067/mob.2001.112970Search in Google Scholar
Garratty G. Predicting the clinical significance of red cell antibodies with in vitro cellular assays. Transfus Med Rev 1990;IV:297-312.10.1016/S0887-7963(90)70272-6Search in Google Scholar
